CNTX | Complete Context Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Discover real-time Context Therapeutics Inc. Common Stock (CNTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
费城,2025年4月1日(环球新闻通讯)-- Context Therapeutics Inc.("Context"或"公司")(纳斯达克:CNTX),一家临床阶段的生物制药公司,正在推动T细胞介导的治疗。 GlobeNewswire04/01 19:30 Context Therapeutics: 2024年财务和战略亮点 TipRanks04/01 11:55 ...
quotes Price Overview Performance Report charts Interactive Chart Snapshot Chart technicals Barchart Opinion Trading Strategies Top Trade Alerts Technical Analysis Trader's Cheat Sheet Seasonal Returns Price History Historical Data company News & Headlines Key Statistics SEC Filings Stock Comparison Insider ...
智通财经APP获悉,宜明昂科-B(01541)早盘涨超14%,截至发稿,涨11.59%,报3.66港元,成交额812.2万港元。 消息面上,宜明昂科公布,根据与Instil Bio的全资附属SYNBIOTX有关IMM2510及IMM27M的授权及合作协议,公司已自SynBioTx收取500万美元的近期付款。目前,根据授权及合作协议,公司已收取首付款及近期付款合共1500万美元...
2025-04-12 istockphoto.com.,2965,2025-04-12 dropboxapi.com.,2966,2025-04-12 vgwort.de.,2967,2025-04-12 xinqiucc.com.,2968,2025-04-12 aso1.net.,2969,2025-04-12 p7cloud.net.,2970,2025-04-12 uol.com.br.,2971,2025-04-12 d2r1yp2w7bby2u.cloudfront.net.,2972,2025-04-12 ...
智通财经APP获悉,安信国际发布研究报告称,复星医药(02196)通过前瞻布局与BioNTech(BNTX.US)合作开发新冠疫苗,且从技术路径上,mRNA疫苗技术安全性高及有效性好,作为控制新冠疫情的有力武器,未来公司有望凭借强有力的研发管线加速创新转型,建议积极关注。 报告中称,2020年3月复星医药与Biontech签订战略合作协议,公司前瞻...
就媒体关于熔断机制推出前是否进行了充分评估、后续会否恢复的问题,刘士余表示,研究论证、实施熔断机制的根本出发点是为了防止股市巨幅波动、保护投资者,推出前经广泛征求意见也达成了相当的共识,但实施过程中造成助跌的效果,制度运行结果与初衷基本背离,考虑到我国市场主体结构短期内不会发生根本性变化,未来几年不具备推行...
智通财经APP获悉,摩根大通指出,美国小型制药商Viking Therapeutics(VKTX.US)旗下减肥药物VK2735即将公布早期试验结果。小摩予该股“增持”评级,目标价为80美元,并将该股列入积极观察名单。受此消息提振,Viking Therapeutics(VKTX.US)周三收涨11.31%,报60.83美元。
This company could not care less about its employees. They pay more than other places because they want to have a lot of applications, not because they want to take care of their employees. We are another type of stock for them, not human beings. ...